Information Library
Results for: Oncology - High-quality studies - Phase II/III
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Forms New Biomarker Research and Development Company
Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.
-
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries
Presentation — October 1, 2010
Download Christopher Ung of Quintiles recent presentation, Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries from the Clinical Development of Cancer Drugs in China -
Personalized Anti-Cancer Therapy Development in China
Presentation — October 1, 2010
Download the slides from Michael Shi, M.D. of Novartis recent presentation, Personalized Anti-Cancer Therapy Development in China from the Clinical Development of Cancer Drugs in China -
Validated Biomarker Menu
Brochure — July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays.
Page 1 of 1 (6 results)
